- Subscribe
- Premium
- C-Suite
- Insiders
- M&A
- Gurus
- Spinoffs
- Buybacks
- More
| Stock | Company | % Portfolio | Shares Held | Market Value | Change in Shares | % Change | Quarter End Price | Source |
|---|---|---|---|---|---|---|---|---|
| PATH | UiPath, Inc. | 58.84% | 30,950,000 | $336,426,500 | 5,742,372 | 22.78% | 13G | |
| WK | WORKIVA INC | 2.61% | 250,000 | $14,907,500 | 100,000 | 66.67% | $59.63 | 13F |
| CLDX | CELLDEX THERAPEUTICS INC NEW | 1.73% | 312,316 | $9,906,664 | 68,516 | 28.1% | $31.72 | 13F |
| ARWR | ARROWHEAD PHARMACEUTICALS IN | 1.39% | 127,198 | $7,975,315 | 30,263 | 31.22% | $62.7 | 13F |
| NKTR | NEKTAR THERAPEUTICS | 1.30% | 103,037 | $7,413,512 | 33,750 | 48.71% | $71.95 | 13F |
| PHVS | PHARVARIS N V | 1.09% | 221,611 | $6,260,511 | 26,999 | 13.87% | $28.25 | 13F |
| ALKS | ALKERMES PLC | 0.99% | 159,791 | $5,650,210 | 18,619 | 13.19% | $35.36 | 13F |
| AGIO | AGIOS PHARMACEUTICALS INC | 0.98% | 164,839 | $5,576,503 | 2,821 | 1.74% | $33.83 | 13F |
| IMVT | IMMUNOVANT INC | 0.95% | 218,507 | $5,427,714 | 52,320 | 31.48% | $24.84 | 13F |
| KRYS | KRYSTAL BIOTECH INC | 0.89% | 19,668 | $5,080,638 | 7,854 | 66.48% | $258.32 | 13F |
| DYN | DYNE THERAPEUTICS INC | 0.82% | 258,132 | $4,679,933 | 10,135 | 4.09% | $18.13 | 13F |
| AMLX | AMYLYX PHARMACEUTICALS INC | 0.77% | 317,877 | $4,418,490 | 45,049 | 16.51% | $13.9 | 13F |
| MBX | MBX BIOSCIENCES INC | 0.76% | 145,480 | $4,342,578 | 2,153 | 1.5% | $29.85 | 13F |
| HRMY | HARMONY BIOSCIENCES HLDGS IN | 0.58% | 119,340 | $3,342,713 | 36,516 | 44.09% | $28.01 | 13F |
| SLN | SILENCE THERAPEUTICS PLC | 0.58% | 630,161 | $3,320,948 | 264,792 | 72.47% | $5.27 | 13F |